Agilent Technologies Surges to 203rd in Trading Volume with $439 Million Turnover

On May 29, 2025, Agilent Technologies (A) saw a significant increase in trading volume, with a turnover of $439 million, marking a 44.5% rise from the previous day. This surge placed Agilent at the 203rd position in terms of trading volume for the day. The stock price of Agilent Technologies rose by 2.16%.

Agilent Technologies reported strong financial results for the second quarter of fiscal year 2025, with revenue reaching $1.67 billion, reflecting a 6% year-over-year increase. The company's earnings per share (EPS) stood at $1.31, marking a 7% growth compared to the same period last year. This performance exceeded analyst estimates, contributing to the positive market sentiment.

Agilent's operating margin for the quarter was 25.1%, demonstrating the company's ability to manage costs effectively despite incremental tariff expenses. The gross margin was 54.1%, influenced by factors such as tariffs, currency fluctuations, and product mix. The company's cash flow from operations was $221 million, with capital expenditures amounting to $114 million. Agilent also repurchased shares worth $165 million and paid dividends totaling $70 million.

The company's CrossLab Group reported revenue of $713 million, driven by a 9% growth in consumables and automation. The Life Sciences and Diagnostics Market Group generated $654 million in revenue, with a 3% increase, particularly strong in the Pathology and NASD segments. The Applied Markets Group's revenue was $301 million, remaining flat on a core growth basis. Agilent's PFAS testing business experienced over 70% year-over-year growth globally, significantly contributing to the company's overall performance.

Despite these positive results, Agilent faced challenges in certain end markets. The academia and government sector saw a modest 2% decline, while biopharma growth was slower due to funding issues in small and mid-sized biotech companies, primarily in the US. The company also experienced a mid-single-digit decline in its NGS business and had to absorb 55 basis points of incremental tariff costs, impacting gross margins. Agilent anticipates potential additional tariff impacts if US-EU tariffs increase, which could add $40 million in gross exposure in the second half of the year.